课题基金 / 基金详情

Career Enhancement Program

Career Enhancement Program
职业提升计划
批准号:
10415942
负责人:
Jennifer A. Wargo
金额:
$9.58万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-16 至 2024-05-31

项目摘要

项目成果

Jennifer A. Wargo的其他基金

相似基金

相关文献

中文摘要
翻译
职业提升计划:项目概要/摘要 职业提升计划(CEP)的目标是利用翻译研究资源, MD安德森癌症中心(MDACC)征求和奖励感兴趣的学院级研究人员密集 在黑色素瘤研究领域的职业发展,以提高黑色素瘤的早期发现,预防, 和治疗。经验丰富的导师服务,以协助CEP获奖者发展他们的职业生涯作为黑色素瘤 专家,目标是减少这种疾病的发病率和死亡率。CEP将支持多达 三次为期一年的奖金,每年50 000美元,根据可接受的进展情况,第二年可续发。 CEP的资金包括在整个奖励期间每年从SPORE获得的5万美元, 以及MDACC每年高达10万美元的机构“匹配基金”。候选人将包括 来自我们机构以及整个德克萨斯州医学中心最有前途的学院级研究人员 中心,和其他孢子,与我们互动。选择CEP获奖者将基于 科学的独特性,质量和研究提案的新奇性以及指导的适当性 我们的内部和外部咨询委员会(IAB; EAB)将对该计划进行评估和评分。的 获奖者将定期与他们指定的导师会面,并至少每月与CEP领导会面, 预计将参加并报告他们的进展,在每月的SPORE调查会议和年度 IAB/EAB会议。CEP由Elizabeth Grimm博士领导,为具有实验室项目的学员提供指导, 博士杰弗里·E. Lee为临床项目的学员提供指导;两人都将参与指导转化研究人员。
英文摘要
Career Enhancement Program: Project Summary/Abstract The goal of the Career Enhancement Program (CEP) is to use the translational research resources at the MD Anderson Cancer Center (MDACC) to solicit and award faculty-level investigators interested in intensive career development in the field of melanoma research to improve melanoma early detection, prevention, and treatment. Experienced mentors serve to assist CEP awardees to develop their careers as melanoma experts, with the goal to reduce the morbidity and mortality from this disease. The CEP will support up to three one-year awards of $50,000 annually, with a second-year renewal based on acceptable progress. Funds for the CEP include an annual $50,000 from the SPORE throughout the duration of the overall award, as well as up to $100,000 per year in institutional “matching funds” from MDACC. Candidates will include the most promising faculty-level investigators from our institution as well as from the entire Texas Medical Center, and other SPOREs, with which we interact. The selection of CEP awardees will be based on the scientific uniqueness, quality, and novelty of the research proposal and the appropriateness of the mentoring plan, which will be evaluated and scored by our Internal and External Advisory Boards (IAB; EAB). The awardees will meet with their designated mentors regularly and with CEP leadership at least monthly, and are expected to participate in and report their progress at monthly SPORE investigator meetings and annual IAB/EAB meetings. The CEP is led by Dr. Elizabeth Grimm for mentees with laboratory-based projects and Dr. Jeffrey E. Lee for mentees with clinical projects; both will be involved to mentor translational researchers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2 Intrathecal Anti-PD-1 Immunotherapy for Metastatic Melanoma Patients with Leptomeningeal Disease (LMD)
Project 2 Intrathecal Anti-PD-1 Immunotherapy for Metastatic Melanoma Patients with Leptomeningeal Disease (LMD)
Career Enhancement Program
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome
海外基金